Cookson Peirce & Co. Inc. Buys 2,897 Shares of HCA Healthcare, Inc. $HCA

Cookson Peirce & Co. Inc. lifted its position in HCA Healthcare, Inc. (NYSE:HCA) by 191.2% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,412 shares of the company’s stock after buying an additional 2,897 shares during the period. Cookson Peirce & Co. Inc.’s holdings in HCA Healthcare were worth $1,720,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Brighton Jones LLC purchased a new position in shares of HCA Healthcare in the fourth quarter worth approximately $1,021,000. NewEdge Advisors LLC boosted its stake in shares of HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after acquiring an additional 409 shares during the last quarter. Sivia Capital Partners LLC increased its stake in shares of HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares in the last quarter. Jump Financial LLC purchased a new position in HCA Healthcare during the second quarter valued at $2,073,000. Finally, Sei Investments Co. increased its position in HCA Healthcare by 56.3% in the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after buying an additional 49,214 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

HCA opened at $417.57 on Friday. The stock has a market capitalization of $90.40 billion, a price-to-earnings ratio of 13.98, a PEG ratio of 1.45 and a beta of 1.10. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The company has a fifty day moving average of $401.08 and a 200 day moving average of $441.46.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.84 EPS. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.

Analyst Ratings Changes

HCA has been the subject of a number of recent research reports. Mizuho cut their price objective on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a research note on Tuesday, July 28th. Cantor Fitzgerald reduced their price objective on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research note on Tuesday, July 7th. TD Cowen lowered their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research note on Monday, June 22nd. Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a research note on Monday, July 27th. Finally, Weiss Ratings lowered HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $462.64.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.